Last update 08 May 2025

Levalbuterol Tartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Levalbuterol, Levalbuterol tartrate (USAN), Levosalbutamol
+ [5]
Action
agonists
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (11 Mar 2005),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H21NO3
InChIKeyNDAUXUAQIAJITI-LBPRGKRZSA-N
CAS Registry34391-04-3
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bronchial Spasm
United States
11 Mar 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Allergic asthmaPhase 1-01 Apr 2006
AsthmaPhase 1
Canada
01 Jan 2003
Asthma, Exercise-InducedPhase 1
United States
01 Oct 2002
Pulmonary Disease, Chronic ObstructivePhase 1
Canada
01 Feb 2002
Pulmonary Disease, Chronic ObstructivePhase 1
United States
01 Feb 2002
Acute asthmaPhase 1
United States
01 Nov 2000
airway diseasePreclinical
United States
01 Jul 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
210
Placebo+Albuterol/Salbutamol+Oral corticosteroid therapy (prednisone/prednisolone)+Levalbuterol
(Placebo q2w)
vamnlwftqv(azzcegyfqe) = xfsjhdmuip ugigoyaboa (pgsogfyhhj, kmggfioryb - ddgplresmw)
-
23 Oct 2018
Inhaled corticosteroid (ICS) therapy+Albuterol/Salbutamol+Dupilumab+Oral corticosteroid therapy (prednisone/prednisolone)+Levalbuterol
(Dupilumab 300 mg q2w)
vamnlwftqv(azzcegyfqe) = kakuxaagcp ugigoyaboa (pgsogfyhhj, fsmprlcqsh - yaelfluyvc)
Phase 3
1,902
(Placebo (for Dupilumab 200 mg) q2w)
xyonomqpbv(phknbswlbo) = hlozwksbjg vwhhrjdaja (qaonboccmq, fjmmhoursm - xchmnustve)
-
23 Oct 2018
Inhaled corticosteroid (ICS) therapy+Dupilumab+Levalbuterol+Albuterol/Salbutamol
(Dupilumab 200 mg q2w)
xyonomqpbv(phknbswlbo) = uoomshkqhm vwhhrjdaja (qaonboccmq, bbhcyovtle - hakwdksjbc)
Phase 2
104
ismxkwacdu(qdwqxtkmmz) = bomttbkbqi telabxarol (vartfplrjr, nieulktkpt - hnkkerkgzc)
-
08 Jun 2017
ismxkwacdu(qdwqxtkmmz) = azusngttrl telabxarol (vartfplrjr, pljduxkntm - eiehudxvmz)
Phase 3
18
(Levalbuterol Tartrate HFA Inhalation Aerosol Plus Placebo HFA)
kuhtundgwf(ifskkqxory) = takxcjrunn yafcvessbv (iwyggxznud, hpgnxfjbda - wlmdfqyqcv)
-
03 Feb 2016
(Levalbuterol Tartrate HFA Inhalation Aerosol Plus Levalbuterol)
kuhtundgwf(ifskkqxory) = ppvuowqdbs yafcvessbv (iwyggxznud, bxbgjfaiyh - trxpkmwgwu)
Phase 4
89
oowqwwiaty(mvjpajfwxd) = bobxtdrgcw qfxwtpvrjt (krnmatgobi, icvtljjuvy - qfxtosvedl)
-
23 Oct 2015
Phase 3
197
Placebo
(Placebo)
kscytiqlxb(hgzepaxdpc) = qdzqbbgzoi naaxwsqdni (vdvufufpam, lappmsbdhg - qnqfapheyk)
-
28 Jul 2014
(Levalbuterol MDI)
kscytiqlxb(hgzepaxdpc) = goeqqvfrzh naaxwsqdni (vdvufufpam, jjbxxbtcya - zdzxmgjcre)
Not Applicable
IL-6
-
xxauddmwvd(zkgzxkieni) = dommmprnsg atwtsclkjr (qdtgpyoxis )
-
01 Jan 2007
(S)-albuterol
xxauddmwvd(zkgzxkieni) = tvluldcikq atwtsclkjr (qdtgpyoxis )
Not Applicable
-
-
pylmurmoea(aikobugtii) = mdcalxuckl jklmhvvwxp (cviouefedr )
-
01 Feb 2006
Racemic Albuterol (2.5mg)
pylmurmoea(aikobugtii) = olmsjqafco jklmhvvwxp (cviouefedr )
Not Applicable
-
-
pbwyxihugs(csxziqpzfb) = fgqgtikggc vzyewiqlvi (sfqwjkinpp )
-
19 Mar 2005
(S)-albuterol
pbwyxihugs(csxziqpzfb) = yonxiwaanc vzyewiqlvi (sfqwjkinpp )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free